Piermont Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-35,594
| Closed | -$1.12M | – | 256 |
|
|
2016
Q3 | $1.12M | Buy |
35,594
+3,020
| +9% | +$95.2K | 0.27% | 155 |
|
|
2016
Q2 | $916K | Buy |
32,574
+10,504
| +48% | +$295K | 0.24% | 169 |
|
|
2016
Q1 | $802K | Buy |
22,070
+400
| +2% | +$14.5K | 0.26% | 106 |
|
|
2015
Q4 | $867K | Sell |
21,670
-1,440
| -6% | -$57.6K | 0.28% | 107 |
|
|
2015
Q3 | $658K | Hold |
23,110
| – | – | 0.21% | 110 |
|
|
2015
Q2 | $761K | Hold |
23,110
| – | – | 0.23% | 110 |
|
|
2015
Q1 | $665K | Buy |
23,110
+7,760
| +51% | +$223K | 0.2% | 123 |
|
|
2014
Q4 | $418K | Hold |
15,350
| – | – | 0.15% | 117 |
|
|
2014
Q3 | $327K | Buy |
+15,350
| New | +$327K | 0.13% | 139 |
|
|
2014
Q2 | – | Sell |
-8,500
| Closed | -$215K | – | 156 |
|
|
2014
Q1 | $215K | Buy |
+8,500
| New | +$215K | 0.1% | 118 |
|